In which patients should the Model for End-Stage Liver Disease (MELD) score be calculated?

In Which Patients Should MELD Be Calculated

MELD score should be calculated in all patients with cirrhosis being evaluated for TIPS candidacy, those with any decompensating event (ascites, variceal bleeding, hepatic encephalopathy), patients being considered for liver transplantation, and cirrhotic patients undergoing non-hepatic surgery or experiencing acute complications. 1, 2

Primary Indications for MELD Calculation

Patients Undergoing TIPS Evaluation

• Laboratory evaluation to enable calculation of MELD score prior to TIPS creation is routinely performed and should be standard practice. 1
• MELD remains the most accurate predictive model for assessing liver function and post-TIPS survival, with a pooled AUC of 0.81 for predicting 90-day mortality after elective TIPS. 1
• MELD performs better in patients receiving TIPS for variceal bleeding than for refractory ascites. 1

Patients with Decompensated Cirrhosis

• MELD should be calculated when patients develop their first major complication, including ascites, variceal bleeding, or hepatic encephalopathy, as these events trigger transplant referral consideration. 3
• The presence of ascites alone carries significant mortality risk and warrants MELD calculation independent of transplant consideration. 3
• MELD accurately predicts short-term mortality in decompensated cirrhosis, variceal bleeding, hepatorenal syndrome, and hepatopulmonary syndrome. 2, 4

Liver Transplant Evaluation and Allocation

• MELD ≥15 is the established threshold for transplant listing, making calculation essential for all patients being considered for liver transplantation. 2, 3
• MELD score drives organ allocation in most European countries and the United States, prioritizing patients based on objective mortality risk. 2
• Patients with MELD ≤14 have better 1-year survival without transplantation than with it, making this a critical decision point. 2, 3

Specific Clinical Scenarios Requiring MELD Calculation

Acute Complications

• Variceal bleeding: MELD predicts mortality and guides management decisions. 4, 5
• Hepatorenal syndrome: MELD assessment is critical, as Type I hepatorenal syndrome has median survival less than 2 weeks without transplant. 3, 4
• Alcoholic hepatitis: MELD ≥18 indicates poor prognosis and should be calculated in all cases. 6, 5
• Spontaneous bacterial peritonitis: Associated with less than 50% survival at 1 year, warranting MELD calculation. 3

Perioperative Risk Assessment

• MELD should be calculated in cirrhotic patients undergoing non-hepatic surgery to assess perioperative mortality risk. 2, 4
• MELD predicts survival after liver resection and other surgical procedures in patients with cirrhosis. 5, 7

Monitoring Frequency Based on Disease Severity

High-Risk Patients (MELD ≥15)

• MELD should be monitored regularly in patients with scores ≥15, as they require active transplant listing and prioritization for organ allocation. 2, 6
• Patients with MELD >20 are at high risk of 90-day mortality and require frequent reassessment. 6

Lower-Risk Patients (MELD <15)

• Regular monitoring for disease progression with MELD score reassessment every 3-6 months is recommended. 6
• Consider more frequent calculation if clinical decompensation occurs despite optimal medical management. 2

Important Clinical Caveats

Situations Where MELD May Be Unreliable

• Patients on warfarin or with Fontan circulation: INR may be elevated independent of liver synthetic function, artificially inflating MELD. 6
• Sarcopenia: Serum creatinine may overestimate renal dysfunction in patients with low muscle mass. 2, 6
• Fluid overload: May underestimate renal dysfunction. 2, 6

Conditions Requiring MELD Exception Points

• Hepatocellular carcinoma, hepatopulmonary syndrome, portopulmonary hypertension, and refractory ascites are poorly captured by MELD and require additional consideration. 2, 6, 3
• These conditions warrant standardized exception points because MELD inadequately reflects their mortality risk or transplant benefit. 2, 3

Limitations to Recognize

• MELD fails to predict mortality accurately in approximately 15-20% of patients with end-stage liver disease. 5, 7
• MELD does not capture clinical parameters like ascites severity or encephalopathy grade, which significantly impact prognosis. 6
• Female patients may have worse outcomes than predicted by MELD alone due to gender-related disparities in the scoring system. 6

Practical Algorithm for MELD Calculation

Calculate MELD immediately when:

• Any patient with cirrhosis develops first decompensating event 3
• TIPS procedure is being considered 1
• Transplant evaluation is initiated 2, 3
• Acute complications occur (variceal bleeding, hepatorenal syndrome, spontaneous bacterial peritonitis) 3, 4
• Non-hepatic surgery is planned in cirrhotic patient 2, 4
• Alcoholic hepatitis is diagnosed 6, 5

Recalculate MELD regularly when:

• Score is ≥15: frequent monitoring for transplant prioritization 2, 6
• Score is <15: every 3-6 months or with clinical change 6
• Post-TIPS: to assess response and predict complications 1